Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease
about
sameAs
Plasmatic level of neurosin predicts outcome of mild cognitive impairment.Involvement of Kallikrein-Related Peptidases in Normal and Pathologic ProcessesPEGylation of interleukin-10 for the mitigation of enhanced pain states.Functional role of kallikrein 6 in regulating immune cell survival.Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.Correlation between KLK6 expression and the clinicopathological features of glioma.Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathyThe tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis.Cellular distribution of human tissue kallikreins: immunohistochemical localization.Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas.Cognitive impairment and dementia in patients with Parkinson disease.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Predictions for the future of kallikrein-related peptidases in molecular diagnostics.Effect of cholecystokinin on experimental neuronal aging.Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects.Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.
P2860
Q21202048-237BBC82-6272-4FCC-B900-76ED2E5F0537Q26771266-0C6E716E-8EC1-4E99-B6EE-78C2C1345A91Q33505369-D5F2C2B7-829D-4EE1-A5B0-BB2BE8BF4018Q33862447-2A2E5436-F6DA-449E-98D3-00F8A84ED66DQ33898347-96E638BF-4B74-4201-8E85-D601B7D809D8Q33898352-7595F3DF-4F29-424E-A930-F4EED555CE41Q34226804-ED227713-29DA-4925-AABF-BA263A96C9E0Q34544824-6743FA00-D11B-497D-9F17-5169B3E6AB1CQ35861497-0C15B676-8C3D-4C37-A1C7-A1C956579B7FQ35987823-D02D98CB-5EDA-4845-A7C8-4246CD9F7B92Q36519359-BB7DC870-4FB5-4352-8487-3EFE37552A3FQ36904004-B58B8A27-EED5-4FF5-933C-B540EC455255Q37597279-83146883-1246-42FB-B9BE-9F7B972895DCQ37952006-03D8D07E-2039-413F-89C0-9F0998F9B76CQ38220044-A46B6548-D48C-44B6-ADEA-5324E7FB3450Q40473261-892CBAD9-56DE-4426-9AA7-6B9E681B6C3BQ46830854-1806569F-0CAB-40E6-A6D2-ECE3C883F916Q49599316-162F2368-AD6E-4437-B321-0BE9D1BACD15
P2860
Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@ast
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@en
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@nl
type
label
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@ast
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@en
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@nl
prefLabel
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@ast
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@en
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@nl
P2093
P2860
P921
P3181
P1476
Decreased cerebrospinal fluid ...... factor for Alzheimer's disease
@en
P2093
Akira Okui
Hidetoshi Uemura
Nozomi Yamaguchi
Shinichi Mitsui
Tatsuo Yamada
Yoshio Yamamura
P2860
P304
P3181
P356
10.1111/J.1749-6632.2002.TB04818.X
P407
P577
2002-11-01T00:00:00Z